drug · small molecule
patient view →vamorolone
Marketedupdated 2mo agoby ReveraGen BioPharma Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for duchenne muscular dystrophy and 5 investigational indications.
indications
investigational
Duchenne Muscular Dystrophy
targets
Glucocorticoid receptorMineralocorticoid receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that